DLA Piper is a global law firm with lawyers worldwide. It provides its clients with legal and business solutions locally, regionally and internationally using integrated teams of lawyers with experience that spans a broad range of disciplines. DLA Piper is widely recognized for its pioneering approach and extensive geographic reach, which enables the practice to look after the business issues that matter to its clients - whether they are large or small. Clients of DLA Piper include single-owner startups, local and household name companies, multinationals, financial institutions, FTSE and Fortune 500 enterprises and their subsidiaries, public bodies and governments.
Analysis Group is one of the largest international economics consulting firms, with more than 950 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.
Tony Pezzano is a partner in the New York offices of DLA Piper LLP. Tony has successfully tried numerous cases in federal district courts and the ITC involving technology innovation across a diverse range of industries. Tony has been lead counsel for brand pharmaceutical companies in over two dozen filed Hatch-Waxman cases during the past ten years involving antibiotic, antiviral, antifungal, anticoagulant, and anti-organ transplant rejection drug products. Tony has also represented both Complainants and Respondents in ITC Section 337 investigations involving biologics, SeaDoos/WaveRunners, wireless communication devices, computer routers and Segways/hoverboards. Few attorneys, if any, can match Tony’s record of obtaining both injunctions in Hatch-Waxman cases as well as exclusion and cease and desist orders in Section 337 investigations. Tony is ITCTLA Past President (2009).
Andrew Clarke provides financial and economic consulting services to clients in both litigation and non-litigation contexts. His engagements have spanned numerous practice areas, including intellectual property (IP), commercial disputes, valuation, securities, and antitrust. Mr. Clarke has consulted in IP matters involving patent, copyright, and trade secret claims before US district courts and the US International Trade Commission (ITC). Recently, his case work has included analyzing domestic industry, remedy, and public interest issues at the ITC; assessing damages related to patent infringement; and determining the fair market value of businesses. He also has experience in commercial disputes involving breaches of contract, tax controversies, insurance recovery, class certification, and fraudulent conveyance, and he has analyzed both liability and damages for antitrust and competition engagements. Mr. Clarke has provided support for clients and testifying experts at all stages of the litigation process, from pre-litigation consulting and discovery to trial and post-trial appeals. He has published expert analysis in Law360 on topics such as standard essential patents, IP damages, and the ITC. He is a CFA (Chartered Financial Analyst) charter holder.